Literature DB >> 18437408

The value of herbal medicines in the treatment of acute non-purulent rhinosinusitis. Results of a double-blind, randomised, controlled trial.

Stefan Tesche1, Frank Metternich, Uwe Sonnemann, Jan-Christian Engelke, Uwe Dethlefsen.   

Abstract

In a prospective, randomised, double-blinded controlled study, we compared the efficacy and safety of two different treatment options with the herbal medicines cineole and a combination of five different components for acute viral rhinosinusitis. One hundred and fifty patients with acute and viral rhinosinusitis (75 patients in each treatment group) were enrolled. The diagnosis rhinosinusitis was made according to a defined symptoms-sum-score which was based on rhinoscopic and clinical signs which are characteristic for rhinosinusitis. The primary endpoint was the amelioration of the symptoms-sum-score, which includes all relevant characteristics for rhinosinusitis as headache on bending, frontal headache, sensitivity of pressure points of trigeminal nerve, impairment of general condition, nasal obstruction, rhino-secretion, secretion quantity, secretion viscosity and fever in a treatment period of 7 days. The mean reduction of the symptoms-sum-score after 4 days was 6.7 (+/-3.4) and after 7 days 11.0 (+/-3.3) in the cineole group and 3.6 (+/-2.8) after 4 days and 8.0 (+/-3.0) after 7 days in the control group. The differences between both groups were clinically relevant and statistically significant after 4 and 7 days (P < 0.0001). This result is validated by the amelioration of the secondary endpoints headache on bending, frontal headache, sensitivity of pressure points of trigeminal nerve, impairment of general condition, nasal obstruction and rhino-secretion. These findings correlate with the statistically significant difference of the estimation of B-scan ultrasonography. It is safe to use both medications for 7 days in patients with acute viral rhinosinusitis. Treatment with cineole is clinically relevant and statistically significant, more effective in comparison to the alternative herbal preparation with five different components.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18437408     DOI: 10.1007/s00405-008-0683-z

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  4 in total

Review 1.  Diagnosis and management of sinusitis.

Authors:  K L Evans
Journal:  BMJ       Date:  1994-11-26

2.  [Effects of standardized Myrtol in therapy of acute sinusitis--results of a double-blind, randomized multicenter study compared with placebo].

Authors:  P Federspil; R Wulkow; T Zimmermann
Journal:  Laryngorhinootologie       Date:  1997-01       Impact factor: 1.057

3.  Therapy for acute nonpurulent rhinosinusitis with cineole: results of a double-blind, randomized, placebo-controlled trial.

Authors:  Wolfgang Kehrl; Uwe Sonnemann; Uwe Dethlefsen
Journal:  Laryngoscope       Date:  2004-04       Impact factor: 3.325

4.  Placebo-controlled, randomized double-blind clinical trial with Sinupret® sugar coated tablets on the basis of a therapy with antibiotics and decongestant nasal drops in acute sinusitis.

Authors:  N Neubauer; R W März
Journal:  Phytomedicine       Date:  1994-12       Impact factor: 5.340

  4 in total
  10 in total

1.  [Rhinosinusitis guidelines--unabridged version: S2 guidelines from the German Society of Otorhinolaryngology, Head and Neck Surgery].

Authors:  B A Stuck; C Bachert; P Federspil; W Hosemann; L Klimek; R Mösges; O Pfaar; C Rudack; H Sitter; M Wagenmann; R Weber; K Hörmann
Journal:  HNO       Date:  2012-02       Impact factor: 1.284

2.  Cloning, functional characterization and genomic organization of 1,8-cineole synthases from Lavandula.

Authors:  Zerihun A Demissie; Monica A Cella; Lukman S Sarker; Travis J Thompson; Mark R Rheault; Soheil S Mahmoud
Journal:  Plant Mol Biol       Date:  2012-05-17       Impact factor: 4.076

Review 3.  Decongestants, antihistamines and nasal irrigation for acute sinusitis in children.

Authors:  Nader Shaikh; Ellen R Wald
Journal:  Cochrane Database Syst Rev       Date:  2014-10-27

4.  [Guideline for "rhinosinusitis"-long version : S2k guideline of the German College of General Practitioners and Family Physicians and the German Society for Oto-Rhino-Laryngology, Head and Neck Surgery].

Authors:  B A Stuck; A Beule; D Jobst; L Klimek; M Laudien; M Lell; T J Vogl; U Popert
Journal:  HNO       Date:  2018-01       Impact factor: 1.284

Review 5.  [Phytomedicine in otorhinolaryngology - evidence-based medicine with medicinal plants].

Authors:  S Sertel
Journal:  HNO       Date:  2011-12       Impact factor: 1.284

6.  Identification, Functional Characterization, and Evolution of Terpene Synthases from a Basal Dicot.

Authors:  Mosaab Yahyaa; Yuki Matsuba; Wolfgang Brandt; Adi Doron-Faigenboim; Einat Bar; Alan McClain; Rachel Davidovich-Rikanati; Efraim Lewinsohn; Eran Pichersky; Mwafaq Ibdah
Journal:  Plant Physiol       Date:  2015-07-08       Impact factor: 8.340

Review 7.  Phytoneering: a new way of therapy for rhinosinusitis.

Authors:  D Passali; J Cambi; F M Passali; L M Bellussi
Journal:  Acta Otorhinolaryngol Ital       Date:  2015-02       Impact factor: 2.124

8.  Spicae aetheroleum in uncomplicated acute bronchitis: a double-blind, randomised clinical trial.

Authors:  Christian Kähler; Tadeusz Derezinski; Joanna Bocian-Sobkowska; Andrea Keckeis; Gabriele Zacke
Journal:  Wien Med Wochenschr       Date:  2017-12-05

9.  Phytomedicine in otorhinolaryngology and pulmonology: clinical trials with herbal remedies.

Authors:  Koosha Ghazi-Moghadam; Hasan Mete Inançlı; Nazanin Bazazy; Peter K Plinkert; Thomas Efferth; Serkan Sertel
Journal:  Pharmaceuticals (Basel)       Date:  2012-08-20

Review 10.  Complementary and integrative treatments: rhinosinusitis.

Authors:  Malcolm B Taw; Chau T Nguyen; Marilene B Wang
Journal:  Otolaryngol Clin North Am       Date:  2013-04-28       Impact factor: 3.346

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.